Imagine a disease that not only impacts 10 million people yearly but also challenges the world with drug-resistant strains. That disease is tuberculosis (TB), and it’s a silent crisis affecting lives across all backgrounds—even stars like Nelson Mandela, who battled TB during his time in prison.
Fortunately, we are now seeing biotech innovations that are rewriting the fight against this resilient disease—from rapid diagnostic testing and gene sequencing for targeted therapies to groundbreaking vaccine research.